USA v. Decinces et al

  1. May 02, 2017

    Ex-MLB Player's Stock Deal Too Good To Be True, Jury Told

    Prosecutors told a California federal jury Tuesday that a stock deal that netted former Major League Baseball player Doug DeCinces $1.3 million was "too good to be true" during closing arguments in the insider trading trial of DeCinces and the former CEO of a medical device company.

  2. April 26, 2017

    Feds, Ex-MLB Star Clash Over Insider Trading Jury Instructions

    Former Major League Baseball player Doug DeCinces and federal prosecutors traded jabs in filings in California federal court Tuesday over proposed jury instructions in a case alleging the athlete, his friend and a former CEO traded on nonpublic information about a medical device company's merger plans.

  3. April 18, 2017

    Ex-MLB Player Says Limit Insider Trading Trial Instruction

    Former Major League Baseball player Doug DeCinces asked a California federal court on Monday to instruct the jury hearing a case against him over insider trading charges that certain testimony at trial does not apply to him.

  4. April 07, 2017

    Gov't Fights Over Facts In Ex-MLB Insider Trading Trial

    Prosecutors told a California federal judge Thursday that former Major League Baseball player Doug DeCinces and his associates can't be acquitted because there's more than enough evidence to tie them to trading on nonpublic tips about a medical device company, but the ex-CEO in the case said the feds were twisting facts.

  5. April 05, 2017

    Ex-MLB Player Seeks Acquittal On Insider Trading Charges

    Former Major League Baseball player Doug DeCinces asked a California federal court Wednesday to acquit him of insider trading charges, saying the government has provided no proof, before trial or during, that he profited from nonpublic merger tips about a friend's medical device company.

  6. April 04, 2017

    Gov't Says Ex-MLBer Can't Admit 'Sloppy' Notes In Trial

    U.S. prosecutors urged a California federal judge not to allow former Major League Baseball player Doug DeCinces, who is being tried on insider trading charges, to admit investigation notes that he says shows investigators were "incomplete, sloppy and biased" into evidence, arguing the notes are hearsay.

  7. March 22, 2017

    Ex-MLBer Says Notes Show 'Sloppy' Insider Trading Probe

    Former Major League Baseball player Doug DeCinces urged a California federal judge to allow him to present investigation notes, including ones from an interview with the government's chief witness, to show "biased and sloppy investigative work by law enforcement agents" as DeCinces fights insider trading charges that he received nonpublic merger tips about a friend's medical device company.

  8. March 09, 2017

    Ex-MLB Player Gamed $1.3M From CEO Pal's Tips, Jury Hears

    Federal prosecutors on Thursday opened a California insider trading trial with claims former Baltimore Orioles player Doug DeCinces made $1.3 million from nonpublic merger tips about a friend's medical device company, but the retired athlete's attorney countered that the government's case hinged on a "biased and sloppy investigation."

  9. December 14, 2016

    Reluctant Judge OKs 7-Wk Insider Trading Trial For Ex-Oriole

    A California federal judge reluctantly approved a seven-week trial on Tuesday for insider trading charges against a former medical device executive and a former Baltimore Orioles player in the wake of the U.S. Supreme Court's Salman ruling.

  10. April 05, 2016

    Ex-CEO Wants Stay In Former Oriole's Insider Trading Suit

    The former head of a medical device company accused of passing insider information to ex-Baltimore Orioles player Doug DeCinces urged a California federal court again on Monday to pause the suit against him pending the outcome of a U.S. Supreme Court case.

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!